Functional selectivity of adenosine receptor ligands

Purinergic Signalling

Volumn 7, Issue 2, 2011, Pages 171-192

  Verzijl, Dennis ^a   IJzerman, Ad P ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Adenosine; Arrestin; Biased signaling; Functional selectivity; Receptor; Scaffold protein

Indexed keywords

EID: 79960984880     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-011-9232-0     Document Type: Review

References (126)

1. Kristiansen K (2004) Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacol Ther 103(1): 21-80.
2. Milligan G, Kostenis E (2006) Heterotrimeric G-proteins: a short history. Br J Pharmacol 147(Suppl 1): S46-55.
3. Schmid CL, Bohn LM (2009) Physiological and pharmacological implications of beta-arrestin regulation. Pharmacol Ther 121(3): 285-293.
4. Oakley RH, Laporte SA, Holt JA, Caron MG, Barak LS (2000) Differential affinities of visual arrestin, βarrestin1, and βarrestin2 for G protein-coupled receptors delineate two major classes of receptors. J Biol Chem 275(22): 17201-17210.
5. Kohout TA, Lin FS, Perry SJ, Conner DA, Lefkowitz RJ (2001) β-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. Proc Natl Acad Sci USA 98(4): 1601-1606.
6. Rajagopal S, Rajagopal K, Lefkowitz RJ (2010) Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat Rev Drug Discov 9(5): 373-386.
7. Hall RA, Lefkowitz RJ (2002) Regulation of G protein-coupled receptor signaling by scaffold proteins. Circ Res 91(8): 672-680.
8. Patel CB, Noor N, Rockman HA (2010) Functional selectivity in adrenergic and angiotensin signaling systems. Mol Pharmacol 78(6): 983-992.
9. Zhang M, Liu X, Zhang Y, Zhao J (2010) Loss of βarrestin1 and βarrestin2 contributes to pulmonary hypoplasia and neonatal lethality in mice. Dev Biol 339(2): 407-417.
10. Kenakin T (2011) Functional selectivity and biased receptor signaling. J Pharmacol Exp Ther 336(2): 296-302.
11. Kenakin T, Miller LJ (2010) Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery. Pharmacol Rev 62(2): 265-304.
12. May LT, Leach K, Sexton PM, Christopoulos A (2007) Allosteric modulation of G protein-coupled receptors. Annu Rev Pharmacol Toxicol 47: 1-51.
13. Göblyös A, IJzerman AP (2011) Allosteric modulation of adenosine receptors. Biochim Biophys Acta 1808(5): 1309-1318.
14. Fredholm BB, IJzerman AP, Jacobson KA, Linden J, Müller CE (2011) International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors-an update. Pharmacol Rev 63(1): 1-34.
15. Walters RW, Shukla AK, Kovacs JJ, Violin JD, DeWire SM, Lam CM, Chen JR, Muehlbauer MJ, Whalen EJ, Lefkowitz RJ (2009) β-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice. J Clin Invest 119(5): 1312-1321.
16. Semple G, Skinner PJ, Gharbaoui T, Shin YJ, Jung JK, Cherrier MC, Webb PJ, Tamura SY, Boatman PD, Sage CR, Schrader TO, Chen R, Colletti SL, Tata JR, Waters MG, Cheng K, Taggart AK, Cai TQ, Carballo-Jane E, Behan DP, Connolly DT, Richman JG (2008) 3-(1 H-tetrazol-5-yl)-1, 4, 5, 6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in mice. J Med Chem 51(16): 5101-5108.
17. Melief EJ, Miyatake M, Bruchas MR, Chavkin C (2010) Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling. Proc Natl Acad Sci USA 107(25): 11608-11613.
18. Sun Y, Huang J, Xiang Y, Bastepe M, Juppner H, Kobilka BK, Zhang JJ, Huang XY (2007) Dosage-dependent switch from G protein-coupled to G protein-independent signaling by a GPCR. EMBO J 26(1): 53-64.
19. Kohout TA, Nicholas SL, Perry SJ, Reinhart G, Junger S, Struthers RS (2004) Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7. J Biol Chem 279(22): 23214-23222.
20. Zidar DA, Violin JD, Whalen EJ, Lefkowitz RJ (2009) Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands. Proc Natl Acad Sci USA 106(24): 9649-9654.
21. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53(4): 527-552.
22. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M (1994) Nomenclature and classification of purinoceptors. Pharmacol Rev 46(2): 143-156.
23. 2B adenosine receptor protects against inflammation and excessive vascular adhesion. J Clin Invest 116(7): 1913-1923.
24. Klaasse EC, IJzerman AP, de Grip WJ, Beukers MW (2008) Internalization and desensitization of adenosine receptors. Purinergic Signal 4(1): 21-37.
25. Müller CE, Jacobson KA (2010) Recent developments in adenosine receptor ligands and their potential as novel drugs. Biochim Biophys Acta 1808(5): 1290-1308.
26. Schulte G, Fredholm BB (2003) Signalling from adenosine receptors to mitogen-activated protein kinases. Cell Signal 15(9): 813-827.
27. 3 receptors expressed in Chinese hamster ovary cells all mediate the phosphorylation of extracellular-regulated kinase 1/2. Mol Pharmacol 58(3): 477-482.
28. Ferre S, Ciruela F, Quiroz C, Lujan R, Popoli P, Cunha RA, Agnati LF, Fuxe K, Woods AS, Lluis C, Franco R (2007) Adenosine receptor heteromers and their integrative role in striatal function. Scientific World Journal 7: 74-85.
29. 1-adenosine receptor. J Biol Chem 269(51): 32077-32084.
30. 1 receptor to phospholipase C in transfected CHO cells. Eur J Pharmacol 355(1): 85-93.
31. 1 receptor: evidence for signaling pathway-dependent changes in agonist potency and relative intrinsic activity. Mol Pharmacol 58(5): 1075-1084.
32. 16-mediated stimulation of phospholipase C. J Neurochem 70(5): 2203-2211.
33. 1 adenosine receptor to different heterotrimeric G proteins: evidence for agonist-specific G protein activation. Br J Pharmacol 143(6): 705-714.
34. Ballesteros JA, Weinstein H (1995) Integrated methods for the construction of three dimensional models and computational probing of structure-function relations in G-protein coupled receptors. Methods in Neuroscience 25: 366-428.
35. 1 adenosine receptor. J Biol Chem 274(6): 3617-3621.
36. 1 receptor involves c-Src, protein kinase C, and ERK signaling. J Biol Chem 279(51): 53196-53204.
37. 1 receptor: synthesis and pharmacological evaluation of 4-substituted 2-amino-3-benzoylthiophenes. J Med Chem 52(14): 4543-4547.
38. 1 adenosine receptor allosteric enhancers. Bioorg Med Chem 16(3): 1319-1327.
39. 1 receptor allosteric modulators. Mol Pharmacol 78(3): 444-455.
40. 3 adenosine receptors: consequences for agonist-stimulated translocation of arrestin3. Biochemistry 41(50): 14748-14761.
41. 1 receptor desensitization and recovery. Am J Physiol Cell Physiol 298(1): C56-65.
42. Germack R, Dickenson JM (2005) Adenosine triggers preconditioning through MEK/ERK1/2 signalling pathway during hypoxia/reoxygenation in neonatal rat cardiomyocytes. J Mol Cell Cardiol 39(3): 429-442.
43. Reid EA, Kristo G, Yoshimura Y, Ballard-Croft C, Keith BJ, Mentzer RM Jr, Lasley RD (2005) In vivo adenosine receptor preconditioning reduces myocardial infarct size via subcellular ERK signaling. Am J Physiol Heart Circ Physiol 288(5): H2253-2259.
44. Germack R, Dickenson JM (2004) Characterization of ERK1/2 signalling pathways induced by adenosine receptor subtypes in newborn rat cardiomyocytes. Br J Pharmacol 141(2): 329-339.
45. 1 adenosine receptors in a pituitary-derived cell line. Brain Res 816(1): 47-57.
46. 1 adenosine receptors. Mol Pharmacol 52(5): 788-797.
47. 2 receptor. J Neurochem 71(2): 799-807.
48. 1 receptors in vivo. J Pharmacol Exp Ther 283(2): 800-808.
49. 6-cyclopentyladenosine in vivo: haemodynamic versus anti-lipolytic responses in rats. Br J Pharmacol 124(3): 607-618.
50. 1-adenosine receptor selectively slows AV conduction in guinea pig hearts. Am J Physiol Heart Circ Physiol 280(1): H334-343.
51. 1 adenosine receptor-mediated responses. Mol Pharmacol 56(2): 316-324.
52. 1 adenosine receptors in pig brain cortical membranes. J Neurochem 66(4): 1675-1682.
53. Ciruela F, Saura C, Canela EI, Mallol J, Lluis C, Franco R (1996) Adenosine deaminase affects ligand-induced signalling by interacting with cell surface adenosine receptors. FEBS Lett 380(3): 219-223.
54. 3H](R)-PIA binding to the caudate nucleus. J Neurochem 107(1): 161-170.
55. 1 adenosine receptors to form functional modules in the cell membrane. Mol Cell Biol 20(14): 5164-5174.
56. 1 adenosine receptors internalize together following agonist-induced receptor desensitization. J Biol Chem 273(28): 17610-17617.
57. Ding Y, Li M, Zhang J, Li N, Xia Z, Hu Y, Wang S, Fan GH (2006) The 73-kDa heat shock cognate protein is a CXCR4 binding protein that regulates the receptor endocytosis and the receptor-mediated chemotaxis. Mol Pharmacol 69(4): 1269-1279.
58. 1 adenosine receptor and adenosine deaminase in an epithelial cell line. Mol Pharmacol 59(5): 1314-1323.
59. 1 adenosine receptors: morphological evidence of endosomal sorting and receptor recycling. Exp Cell Res 285(1): 72-90.
60. + channels by caveolin-enriched microdomains in cardiac myocytes. Cardiovasc Res 82(1): 51-58.
61. 1 receptors translocate out of caveolae. J Biol Chem 275(6): 4417-4421.
62. 1 receptor activation differentially modulate subcellular cardiomyocyte MAPKs. Am J Physiol Heart Circ Physiol 294(1): H263-271.
63. 1 adenosine receptor and inhibits receptor action. Biochem J 377(1): 51-59.
64. Ohno N, Terada N, Tanaka J, Yokoyama A, Yamakawa H, Fujii Y, Baba T, Ohara O, Ohno S (2005) Protein 4. 1 G localizes in rodent microglia. Histochem Cell Biol 124(6): 477-486.
65. olf in rat striatum. Mol Pharmacol 58(4): 771-777.
66. van Calker D, Müller M, Hamprecht B (1979) Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J Neurochem 33(5): 999-1005.
67. 16 couple a wide variety of receptors to phospholipase C. J Biol Chem 270(25): 15175-15180.
68. Klinger M, Kudlacek O, Seidel MG, Freissmuth M, Sexl V (2002) MAP kinase stimulation by cAMP does not require RAP1 but SRC family kinases. J Biol Chem 277(36): 32490-32497.
69. ras-dependent pathway. J Biol Chem 274(36): 25833-25841.
70. 2A-adenosine receptor in primary human endothelial cells. J Biol Chem 272(9): 5792-5799.
71. 2A receptor occupancy stimulates collagen expression by hepatic stellate cells via pathways involving protein kinase A, Src, and extracellular signal-regulated kinases 1/2 signaling cascade or p38 mitogen-activated protein kinase signaling pathway. Mol Pharmacol 72(6): 1626-1636.
72. 2A receptor interacts with the actin-binding protein α-actinin. J Biol Chem 278(39): 37545-37552.
73. 2A adenosine receptor is necessary for sustained activation of the ERK/MAP kinase pathway. J Biol Chem 280(36): 31898-31905.
74. 2A receptor. Mol Pharmacol 69(4): 1083-1094.
75. 2A adenosine receptor via a novel interacting protein, translin-associated protein X. Mol Pharmacol 70(2): 454-466.
76. 2A receptor and modulates the cell surface expression and function of the receptor. Mol Cell Neurosci 36(1): 1-12.
77. 2 receptors. J Proteome Res 7(8): 3428-3434.
78. 2A-adenosine receptor. Biochim Biophys Acta 1808(5): 1350-1357.
79. 2A-adenosine receptor blunts constitutive activity: differential effect on cAMP accumulation and MAP kinase stimulation. Naunyn-Schmiedeberg's Arch Pharmacol 366(4): 287-298.
80. 2B receptor. J Pharmacol Exp Ther 320(2): 637-645.
81. 2A receptor revisited: evidence for physical separation of two signaling cascades. J Biol Chem 283(14): 9276-9288.
82. Braun S, Levitzki A (1979) Adenosine receptor permanently coupled to turkey erythrocyte adenylate cyclase. Biochemistry 18(10): 2134-2138.
83. 2A receptors of NMDA but not AMPA currents in rat neostriatal neurons. Br J Pharmacol 130(2): 259-269.
84. 2 receptors. J Biol Chem 284(41): 28058-28068.
85. 2 receptors. J Biol Chem 277(20): 18091-18097.
86. 2A adenosine receptors in rescuing the nerve growth factor-induced neurite outgrowth impaired by blockage of the MAPK cascade. J Biol Chem 277(37): 33930-33942.
87. 2A adenosine receptor rescues neuritogenesis impaired by p53 blockage via KIF2A, a kinesin family member. Dev Neurobiol 70(8): 604-621.
88. q in human embryonic kidney 293 cells and HMC-1 mast cells. Mol Pharmacol 56(4): 705-713.
89. 2 receptors stimulate mitogen-activated protein kinase in human embryonic kidney-293 cells. cross-talk between cyclic AMP and protein kinase c pathways. J Biol Chem 274(9): 5972-5980.
90. 2B receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. J Clin Invest 96(4): 1979-1986.
91. 2B adenosine receptors. Br J Pharmacol 122(6): 1075-1082.
92. 2B receptor recruits divergent pathways to regulate ERK1/2 and p38. Exp Cell Res 290(1): 168-176.
93. Fang Y, Olah ME (2007) Cyclic AMP-dependent, protein kinase A-independent activation of extracellular signal-regulated kinase 1/2 following adenosine receptor stimulation in human umbilical vein endothelial cells: role of exchange protein activated by cAMP 1 (Epac1). J Pharmacol Exp Ther 322(3): 1189-1200.
94. 2B receptor. Nature 407(6805): 747-750.
95. Rodrigues S, De Wever O, Bruyneel E, Rooney RJ, Gespach C (2007) Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis. Oncogene 26(38): 5615-5625.
96. 2B receptor activation. Science 291(5510): 1976-1982.
97. Rosenberger P, Schwab JM, Mirakaj V, Masekowsky E, Mager A, Morote-Garcia JC, Unertl K, Eltzschig HK (2009) Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat Immunol 10(2): 195-202.
98. 2B receptor activation regulates the response of axons to netrin-1 by controlling cell surface levels of UNC5A receptors. J Neurochem 104(4): 1081-1090.
99. Martin M, Simon-Assmann P, Kedinger M, Mangeat P, Real FX, Fabre M (2006) DCC regulates cell adhesion in human colon cancer derived HT-29 cells and associates with ezrin. Eur J Cell Biol 85(8): 769-783.
100. Sitaraman SV, Wang L, Wong M, Bruewer M, Hobert M, Yun CH, Merlin D, Madara JL (2002) The adenosine 2b receptor is recruited to the plasma membrane and associates with E3KARP and Ezrin upon agonist stimulation. J Biol Chem 277(36): 33188-33195.
101. 2B adenosine receptor switches internalization to an arrestin-and clathrin-independent pathway and inhibits recycling. Br J Pharmacol 159(3): 518-533.
102. Mundell SJ, Loudon RP, Benovic JL (1999) Characterization of G protein-coupled receptor regulation in antisense mRNA-expressing cells with reduced arrestin levels. Biochemistry 38(27): 8723-8732.
103. 2B adenosine receptor trafficking. Biochemistry 39(42): 12828-12836.
104. Wang L, Kolachala V, Walia B, Balasubramanian S, Hall RA, Merlin D, Sitaraman SV (2004) Agonist-induced polarized trafficking and surface expression of the adenosine 2b receptor in intestinal epithelial cells: role of SNARE proteins. Am J Physiol Gastrointest Liver Physiol 287(5): G1100-1107.
105. 2B receptors behave as an alternative anchoring protein for cell surface adenosine deaminase in lymphocytes and cultured cells. Mol Pharmacol 59(1): 127-134.
106. 3 adenosine receptor. J Biol Chem 270(28): 16895-16902.
107. 6 cells. J Membr Biol 178(2): 103-113.
108. 3 adenosine receptor: an enigmatic player in cell biology. Pharmacol Ther 117(1): 123-140.
109. 2 receptors. J Biol Chem 279(9): 7901-7908.
110. Calebiro D, Nikolaev VO, Persani L, Lohse MJ (2010) Signaling by internalized G-protein-coupled receptors. Trends Pharmacol Sci 31(5): 221-228.
111. 3 receptor agonists. Biochem Biophys Res Commun 219(3): 904-910.
112. 3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2 H3 mast cells from apoptosis. Mol Pharmacol 59(1): 76-82.
113. 3 receptors in microglia cells. J Neurochem 86(4): 1051-1054.
114. 3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells. J Biol Chem 280(20): 19516-19526.
115. 3 receptor expressed in Chinese hamster ovary cells to the extracellular signal-regulated kinase 1/2. Mol Pharmacol 62(5): 1137-1146.
116. 3 adenosine receptor activation. Cancer Biol Ther 7(2): 278-284.
117. Kim SG, Ravi G, Hoffmann C, Jung YJ, Kim M, Chen A, Jacobson KA (2002) p53-Independent induction of Fas and apoptosis in leukemic cells by an adenosine derivative, Cl-IB-MECA. Biochem Pharmacol 63(5): 871-880.
118. Lee K, Ravi G, Ji XD, Marquez VE, Jacobson KA (2001) Ring-Constrained (N)-methanocarba nucleosides as adenosine receptor agonists: independent 5′-uronamide and 2′-deoxy modifications. Bioorg Med Chem Lett 11(10): 1333-1337.
119. Lu J, Pierron A, Ravid K (2003) An adenosine analogue, IB-MECA, down-regulates estrogen receptor alpha and suppresses human breast cancer cell proliferation. Cancer Res 63(19): 6413-6423.
120. 3 antagonists. Biochem Biophys Res Commun 232(2): 317-322.
121. 3 adenosine receptor antagonist, truncated Thio-Cl-IB-MECA, induces apoptosis in T24 human bladder cancer cells. Anticancer Res 30(7): 2823-2830.
122. 3 adenosine receptor ligands in an engineered cell line: comparison with G protein-dependent pathways. Pharmacol Res 57(4): 303-311.
123. 3 receptor in transfected CHO cells. Eur J Pharmacol 420(1): 19-26.
124. Santini F, Penn RB, Gagnon AW, Benovic JL, Keen JH (2000) Selective recruitment of arrestin-3 to clathrin coated pits upon stimulation of G protein-coupled receptors. J Cell Sci 113(Pt 13): 2463-2470.
125. 3 adenosine receptor. Mol Pharmacol 57(3): 539-545.
126. Peters MF, Scott CW (2009) Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity. J Biomol Screen 14(3): 246-255.